Cargando…
Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
We report a case of invasive pulmonary aspergillosis in a patient taking ibrutinib, a Bruton's tyrosine kinase inhibitor used to treat refractory chronic lymphocytic leukemia. We hypothesize that ibrutinib promoted this infection by suppressing innate immune responses against Aspergillus. Clini...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369366/ https://www.ncbi.nlm.nih.gov/pubmed/28377877 http://dx.doi.org/10.1016/j.rmcr.2017.03.011 |